John C. Fortney, PhD

Articles by John C. Fortney, PhD

A Web-Based Clinical Decision Support System for Depression Care Management

ByJohn C. Fortney, PhD,Jeffrey M. Pyne, MD,Christopher A. Steven, BA,J. Silas Williams,Richard G. Hedrick, BBA,Amanda K. Lunsford, MA,William N. Raney, MA, RN,Betty A. Ackerman, RN,Loretta O. Ducker, MA, RN,Laura M. Bonner, PhD,Jeffrey L. Smith, BS

November 19th 2010

This article describes the development and capabilities of a Webbased decision support system for care managers working in the context of the chronic care model.

Increasing Copayments and Adherence to Diabetes, Hypertension, and Hyperlipidemic Medications

ByMatthew L. Maciejewski, PhD,Chris L. Bryson, MD, MS,Mark Perkins, PharmD,David K. Blough, PhD,Francesca E. Cunningham, PhD,John C. Fortney, PhD,Sarah L. Krein, PhD,Kevin T. Stroupe, PhD,Nancy D. Sharp, PhD,Chuan-Fen Liu, PhD

January 1st 2010

A copayment increase from $2 to $7 adversely affected veterans' adherence to statins, antihypertensives, and oral hypoglycemic agents.

Latest Updated Articles

Increasing Copayments and Adherence to Diabetes, Hypertension, and Hyperlipidemic Medications
January 1st 2010
A Web-Based Clinical Decision Support System for Depression Care Management
November 19th 2010

John C. Fortney, PhD

Articles by John C. Fortney, PhD

A Web-Based Clinical Decision Support System for Depression Care Management

Increasing Copayments and Adherence to Diabetes, Hypertension, and Hyperlipidemic Medications

Latest Updated Articles

Trending on AJMC

Hans Lee, MD, Discusses “Off-the-Shelf” Solution for Rare Blood Disorder With No Approved Therapies

FDA Approves Another OTC Naloxone Nasal Spray for Opioid Overdose

United Therapeutics Plans FDA Submission for Inhaled Treprostinil in IPF

HDV Combo Shows No Relapses at 2 Years: Tarik Asselah, MD, PhD

Venetoclax-Obinutuzumab Tops Acalabrutinib in First-Line CLL